Osaic Holdings
PMN icon

Osaic Holdings’s ProMIS Neurosciences PMN Stock Holding History

Osaic Holdings’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.74K Hold
360
– – ﹤0.01% 6962
2026
Q1 		$4.57K Hold
360
– – ﹤0.01% 6722
2025
Q4 		$2.47K Hold
360
– – ﹤0.01% 7015
2025
Q3 		$4.77K Buy
+360
New +$4.98K ﹤0.01% 6770

Other funds holding PMN

JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Osaic Holdings's PMN Position: Q2 2026 in Review

Osaic Holdings held its ProMIS Neurosciences (PMN) position steady in Q2 2026 at 360 shares worth $4.74K. The position accounts for ﹤0.01% of the portfolio, ranked #6962.

Osaic Holdings first reported a position in PMN in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.77K in Q3 2025. 27 funds tracked by Wall St. Rank hold PMN as of Q2 2026.

  • Osaic Holdings held 360 shares of ProMIS Neurosciences worth $4.74K as of Q2 2026.
  • Osaic Holdings left its ProMIS Neurosciences share count unchanged in Q2 2026.
  • ProMIS Neurosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6962 holding.
  • Osaic Holdings first reported a position in ProMIS Neurosciences in Q3 2025 and has held it in 4 quarters since.
  • Osaic Holdings's ProMIS Neurosciences position peaked at $4.77K in Q3 2025.
  • 27 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.